Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Usefulness of GHRP-2 test in pituitary adenoma (TSHoma, acromegaly, prolactinoma)
jRCTs021180040Recruiting
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of KP102 in TSH-secreting adenoma (TSHoma), acromegaly and prolactinoma. Primary endpoint: Serum TSH, GH and prolactin levels after administration of GHRP-2. Started May 2019; status: recruiting.
02
Drugs
KP102
03
Conditions
TSH-secreting adenoma (TSHoma)acromegalyprolactinoma
Beyond the preview
Go deeper on jRCTs021180040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021180040.